2024 Approvals

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

What is Wegovy prescribed for?   Wegovy (generic name: semaglutide), pronounced “weh-Go-veeh,” is an injectable prescription medication for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems, to help them lose weight and keep it off. What is the name of the drug and what does it do?  The...

Exciting New Drug Approval: WINREVAIR: March 26, 2024

Exciting New Drug Approval: WINREVAIR: March 26, 2024

What is WINREVAIR prescribed for?  WINREVAIR is prescribed to treat adults with pulmonary arterial hypertension. What is the name of the drug and what does it do? WINREVAIR pronounced WIN-reh-vair, (generic name: sotatercept-csrk) is used to treat adults with pulmonary arterial hypertension (PAH), a condition where there is high blood pressure in the arteries...

FDA Approves Dupixent for Children Suffering from Eosinophilic Esophagitis on January 2024

FDA Approves Dupixent for Children Suffering from Eosinophilic Esophagitis on January 2024

What is Dupixent prescribed for? DUPIXENT (generic name: dupilumab), pronounced DU-pix-ent is prescribed for children aged 1 year and older to treat eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. EoE is caused by a buildup of eosinophils, a type of white blood cell, which leads to damage and inflammation in the esophagus. This can...

FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024

FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024

What is Amtagvi prescribed for?   Amtagvi is prescribed to treat adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. What is the name of the drug and what does it do?  The newly approved drug is called Amtagvi...

FDA Approves Xolair for Food Allergy Management on February 16, 2024

FDA Approves Xolair for Food Allergy Management on February 16, 2024

What is Xolair prescribed for?   Xolair is prescribed to treat food allergy in people 1 year of age and older to reduce allergic reactions that may occur after accidentally eating one or more foods to which you are allergic. What is the name of the drug and what does it do? Xolair, pronounced ZOHL-air, (generic name: omalizumab), a medication previously...

FDA Approves Exciting New Drug TRYVIO For High Blood Pressure on March 20, 2024

FDA Approves Exciting New Drug TRYVIO For High Blood Pressure on March 20, 2024

What is TRYVIO prescribed for?   TRYVIO is a prescription medicine used to treat high blood pressure (hypertension) in adults who are taking other high blood pressure medicines and whose blood pressure is not well controlled. What is the name of the drug and what does it do? TRYVIO pronounced try-vee-oh, (generic name: aprocitentan) is designed to treat...